Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
